首页 | 本学科首页   官方微博 | 高级检索  
检索        

肝癌肝移植Milan标准的临床意义探讨
作者姓名:Shen ZY  Zheng H  Wang ZL  Shen W  Zhu ZJ  Deng YL  Pan C  Bao FK
作者单位:天津市第一中心医院器官移植中心,300192
基金项目:天津市科技发展基金,天津市卫生局资助项目 
摘    要:目的探讨肝癌肝移植Milan标准的临床应用价值和注意事项。方法回顾性分析2001年12月至2005年11月术前cT检查符合Milan标准的125例肝细胞癌行肝移植患者的临床资料,对比影像学与病理学检查结果的差别及其对患者生存时间的影响。结果125例患者中,切除肝脏病理检查证实符合Milan标准者97例,超出Milan标准者26例,2例未发现癌灶最终诊断为结节状肝硬化,准确率为77.6%。影像学与病理学符合Milan标准的肝移植患者的1、2、3、4和5年生存率分别为92.0%和92.8%、87.2%和90.7%、86.4%和89.7%、86.4%和89.7%、86.4%和89.7%,两组间生存率无明显差别(P〉0.05)。病理学上超出Milan标准的患者1、2、3、4和5年生存率分别为73.0%、65.4%、61.5%、61,5%和61.5%,与病理学符合及影像学检查符合组间均存在明显差异(P〈0.05)。结论术前螺旋CT诊断符合Milan标准的肝细胞癌患者肝移植术后生存良好,但应进一步提高诸如门静脉主要分支癌栓、淋巴结转移等导致病期误判因素的诊断水平。

关 键 词:  肝细胞  肝移植  病理学  电子计算机体层扫描

Clinical study of Milan criteria for liver transplantation
Shen ZY,Zheng H,Wang ZL,Shen W,Zhu ZJ,Deng YL,Pan C,Bao FK.Clinical study of Milan criteria for liver transplantation[J].Chinese Journal of Surgery,2007,45(23):1615-1618.
Authors:Shen Zhong-yang  Zheng Hong  Wang Zheng-lu  Shen Wen  Zhu Zhi-jun  Deng Yong-lin  Pan Cheng  Bao Fu-kuan
Institution:Transplant Center, Tianjin First Central Hospital, Tianjin, China.
Abstract:OBJECTIVE: To investigate the value and deficiency of Milan criteria for liver transplantation in patients with hepatocellular carcinoma (HCC). METHODS: Between December 2001 and November 2005, 125 patients underwent orthotopic liver transplantation ( OLT), who measured up Milan criteria with preoperation computerized tomography (CT) scaning. The results of pre-transplant multidetector CT scan and post-transplant pathology were retrospectively analyzed, and survival rates were compared. RESULTS: Pathology examination certificated that 97 cases met Milan criteria (77.6%), 26 cases exceeded Milan criteria,and the other 2 cases were diagnosed as nodular cirrhosis. The 1-,2-,3-,4- and 5-year survival rates for those met pre-transplant multidetector CT scanning pre-transplant met Milan criteria vs. those met post-transplant pathology post-transplant criteria were 92.0% vs. 92.8%, 87.2% vs. 90.7%, 86.4% vs. 89.7%, 86.4% vs. 89.7%, and 86.4% vs. 89.7%, respectively. There was no statistic significant difference (P > 0.05). The 1-,2-,3-,4- and 5-year survival rates were 73.0%, 65.4%, 61.5%, 61.5% and 61.5%, for those pathology exceed Milan criteria respectively. The difference between this group and each of the above two were statistically significant (P < 0.05). CONCLUSIONS: The prognosis of OLT for HCC is good for those met Milan criteria by pre-transplant multidetector CT. Factors leading to poor prognosis such as portal vein tumor thrombi and lymphatic metastasis should be accurately evaluated avoiding for misjudgement.
Keywords:
本文献已被 维普 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号